Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-02-28 Li Ji EVP and Gl. Head of Bus. Dev. Sale −1,749 $143.72 $251K 8,251
2018-02-28 Li Ji EVP and Gl. Head of Bus. Dev. Sale −1,100 $144.78 $159K 7,151
2018-02-28 Li Ji EVP and Gl. Head of Bus. Dev. Sale −1,400 $145.97 $204K 5,751
2018-02-28 Li Ji EVP and Gl. Head of Bus. Dev. Sale −1,800 $146.92 $264K 3,951
2018-02-28 Li Ji EVP and Gl. Head of Bus. Dev. Sale −1,551 $148.66 $231K 2,400
2018-02-28 Li Ji EVP and Gl. Head of Bus. Dev. Sale −2,400 $149.49 $359K 0
2018-02-28 Li Ji EVP and Gl. Head of Bus. Dev. Exercise or conversion · Share Option (Right to Buy) −130,000 2,246,000
2018-01-26 Glazer Donald W. Director Gift −10,873 4,527,634
2018-01-18 BAKER BROS. ADVISORS LP Director Purchase +335,050 $101.00 $33.8M 708,025
2018-01-18 BAKER BROS. ADVISORS LP Director Purchase +1,645,148 $101.00 $166.2M 5,121,404
2017-12-26 OYLER JOHN Chief Executive Officer Sale −8,958 $95.55 $856K 110,179
2017-12-26 OYLER JOHN Chief Executive Officer Sale −8,279 $96.68 $800K 101,900
2017-12-26 OYLER JOHN Chief Executive Officer Sale −1,700 $97.83 $166K 100,200
2017-12-26 OYLER JOHN Chief Executive Officer Sale −200 $99.05 $20K 100,000
2017-12-26 OYLER JOHN Chief Executive Officer Sale −1,000 $100.08 $100K 99,000
2017-12-21 Huang Jane CMO, Hematology Exercise or conversion +1,000 $29.51 $30K 1,000
2017-12-21 Huang Jane CMO, Hematology Sale −1,000 $98.00 $98K 0
2017-12-21 Huang Jane CMO, Hematology Exercise or conversion · Share Option (Right to Buy) −13,000 1,367,500
2017-12-13 Huang Jane CMO, Hematology Exercise or conversion +1,500 $29.51 $44K 1,500
2017-12-13 Huang Jane CMO, Hematology Sale −1,300 $94.21 $122K 200

Page 114 of 123 · 2,455 trades